Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
Takeda Pharmaceutical Company Limited Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference Tuesday, January 12, 2021 3:15PM IST (9:45AM GMT) − − Wave 1 Pipeline Portfolio Includes 12 New Molecular Entities Targeted for Launch by FY2024 Representing Best-in-Class/First-in-Class Therapies with Significant Market Potential − Rapid Deleveraging On Track to Achieve Target of 2x Net Debt / adjusted EBITDA...
United States Christophe Weber Holly Campbell Kazumi Kobayashi International Financial Reporting Standards University Of Texas Md Anderson Cancer Center
Source: businesswireindia.com